Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways

BACKGROUND: Renal cell carcinoma (RCC) has gradually become a severe type of kidney malignant tumor, which warrants an urgent need for highly efficacious therapeutic agents. Morusin, a typical prenylated flavonoid, has been revealed to possess anticarcinogenic effects against several cancers by inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chengfei, Luo, Jing, Luo, Xing, Jia, Weisheng, Fang, Zhenqiang, Yi, Shanhong, Li, Longkun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186639/
https://www.ncbi.nlm.nih.gov/pubmed/32355771
http://dx.doi.org/10.21037/atm.2020.02.107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186639/
https://www.ncbi.nlm.nih.gov/pubmed/32355771
http://dx.doi.org/10.21037/atm.2020.02.107

Ejemplares similares